US FDA approves Bristol Myers Squibb's cancer drug for Hodgkin's lymphoma-June 2024-www.financetom.com

US FDA approves Bristol Myers Squibb's cancer drug for Hodgkin's lymphoma

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves Bristol Myers Squibb's cancer drug for Hodgkin's lymphoma

Mar 20, 2026 9:40 AM

March 20 (Reuters) - The U.S. Food and Drug

Administration on Friday approved Bristol Myers Squibb's ( BMY )

combination treatment for adults and adolescents aged 12 and

older with previously untreated Stage III or IV classical

Hodgkin's lymphoma.

Previous page： Google agrees $36 million fine for anti-competitive deals with Australia telcos Next page： DexCom Adds President Role to COO Jake Leach

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

DexCom Adds President Role to COO Jake Leach

May 26, 2025

09:02 AM EDT, 05/13/2025 (MT Newswires) -- DexCom ( DXCM ) said Tuesday that it has added the role of president to its chief operating officer, Jake Leach. DexCom ( DXCM ) said Leach will now also oversee the company's corporate development and strategic initiatives as part of his expanded position. ...

Bayer: U.S. Supreme Court could decide in June whether it will hear glyphosate case

May 26, 2025

FRANKFURT, May 13 (Reuters) - Bayer said on Tuesday that the U.S. Supreme Court could decide as early as next month whether it will hear the German company's request to sharply limit litigation that could run into the billions of dollars over disputed claims that its Roundup weedkiller causes cancer. There are two windows that we could hear (from the...

Altimmune Secures Credit Facility of Up to $100 Million From Hercules Capital

May 26, 2025

09:03 AM EDT, 05/13/2025 (MT Newswires) -- Altimmune ( ALT ) said Tuesday it entered into an agreement with Hercules Capital ( HTGC ) for a credit facility of up to $100 million, with $15 million funded at closing. The company said additional funding will be tied to the achievement clinical and financial milestones for pemvidutide, its GLP-1 agonist. Pemvidutide...